HemoPoint H2 Hemoglobin DMS of Stanbio approved
Stanbio Laboratory announced that the FDA has approved its HemoPoint H2 Hemoglobin Data Management System (DMS), which provides both a hemoglobin and calculated hematocrit result with one simple test. The new, HemoPoint H2 DMS utilizes connectivity to PCs via Bluetooth, control intervals and barcode identification of operators and patients to offer time-saving convenience, ease of data management technology and high quality control.
-
Siemens Leads By Example In IVD Industry Through Adopting GS1 Standards For Healthcare Product Identification
VITROS(R) 3600 Immunodiagnostic System Receives 510(k) Clearance From The FDA
Breath test for early detection of lung cancer
St. Jude Medical Announces European Approval Of Next-Generation Athena Programmer For The Management Of Deep Brain Stimulation Therapy
Medtronic’s Attain Ability approved
